Amyloid fibrils from the viewpoint of protein folding
Authors:
- 1 March 2004
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 61 (5) , 511-524
Abstract
In amyloid related diseases, proteins form fibrillar aggregates with highly ordered β-sheet structure regardless of their native conformations. Formation of such amyloid fibrils can be reproducible in vitro using isolated proteins/peptides, suggesting that amyloid fibril formation takes place as a result of protein conformational change. In vitro studies revealed that perturbation of the native structure is important for the fibril formation, and it is suggested that the mechanisms of amyloid fibril formation share the mechanisms of protein folding. In particular, amyloid fibril formation is similar to one of the common features of proteins, i.e. amorphous aggregation upon partial unfolding, which is likely driven by hydrophobic interactions through exposed protein interior. However, these molecular associations are distinct phenomena, and identifying factors that lead to amyloid fibril formation would precede our understanding of the mechanisms of amyloid fibrillization. The necessity of understanding the nature of protein denatured states is also suggested.Keywords
This publication has 8 references indexed in Scilit:
- Rapid pacing to facilitate transcatheter prosthetic heart valve implantationCatheterization and Cardiovascular Interventions, 2006
- Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of CardiologyEuropean Heart Journal, 2006
- [Balloon aortic valvuloplasty in the adult. Immediate results and in-hospital complications in the latest series of 141 consecutive patients at the University Hospital of Rouen (2002-2005)].2006
- Treatment of Calcific Aortic Stenosis With the Percutaneous Heart ValveJACC, 2006
- Percutaneous Aortic Valve Implantation Retrograde From the Femoral ArteryCirculation, 2006
- Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosisJACC, 2004
- Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic StenosisCirculation, 2002
- Percutaneous suture closure for management of large French size arterial puncture in aortic valvuloplasty.2001